Author:
Pathan Ejaz,Shenoy Padmanabha,Baraliakos Xenofon
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol [Internet]. 1994;21(12):2286–91. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/7699630
.
2. Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis [Internet]. 2009;68(1):18–24. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18625618
.
3. Brandt J, Listing J, Sieper J, Rudwaleit M, Van Der Heijde D, Braun J. Development and preselection of criteria for short term improvement after anti-TNF alpha Treatment in ankylosing spondylitis. Ann Rheum Dis. 2004;63(11):1438–44.
4. Machado P, Landewé RBM, Braun J, Baraliakos X, Hermann K-GA, Hsu B, Baker D, van der Heijde D. MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor. Ann Rheum Dis [Internet]. 2012;71(12):2002–5. Available from:
http://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2012-201999
.
5. Spoorenberg A, de Vlam K, van der Linden S, Dougados M, Mielants H, van de Tempel H, et al. Radiological scoring methods in ankylosing spondylitis. Reliability and change over 1 and 2 years. J Rheumatol [Internet]. 2004;31(1):125–32. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/14705231
.